
Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Olaf Stamm, PhD, is scientific advisor, biologics testing with Charles River.

Gene therapy products present a unique set of challenges for the control of host cell protein impurities.

Published: July 15th 2021 | Updated: